Key Events This Week
11 May: Stock opens at Rs.529.60, down 2.91% amid market weakness
12 May: Surges to upper circuit at Rs.635.50 on robust buying momentum
13 May: Reports stellar Q4 FY26 results; technical momentum shifts bullish
15 May: Closes week at Rs.696.70, up 16.16% on heavy volume

Sakar Healthcare Ltd is Rated Buy
2026-05-14 10:10:03Sakar Healthcare Ltd is rated Buy by MarketsMOJO, with this rating last updated on 14 May 2026. While the rating change occurred on this date, the analysis and financial metrics discussed here reflect the stock's current position as of 14 May 2026, providing investors with an up-to-date view of the company’s standing.
Read full news articleAre Sakar Healthcare Ltd latest results good or bad?
2026-05-13 19:20:25Sakar Healthcare Ltd's latest financial results for the quarter ended March 2026 demonstrate notable operational performance, characterized by substantial year-on-year growth across key metrics. The company reported a net profit of ₹11.02 crores, reflecting a significant increase of 91.32% compared to the same quarter last year. This growth in net profit was accompanied by a revenue of ₹71.10 crores, which also showed a robust year-on-year increase of 41.52%. The operating margin, excluding other income, reached 36.91%, marking the highest level in the company's recent history and indicating effective cost management and operational efficiency. This margin expansion of 560 basis points from the previous year underscores the company's ability to scale revenues while controlling expenses. Additionally, the profit before tax surged to ₹18.06 crores, up 64.90% quarter-on-quarter and 189.42% year-on-year, driv...
Read full news article











